Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder.

O'Donovan C, Kusumakar V, Graves GR, Bird DC.

J Clin Psychiatry. 2002 Apr;63(4):322-30.

PMID:
12000206
2.

Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report.

Rasgon NL, Altshuler LL, Gudeman D, Burt VK, Tanavoli S, Hendrick V, Korenman S.

J Clin Psychiatry. 2000 Mar;61(3):173-8.

PMID:
10817101
3.

Valproate, bipolar disorder and polycystic ovarian syndrome.

McIntyre RS, Mancini DA, McCann S, Srinivasan J, Kennedy SH.

Bipolar Disord. 2003 Feb;5(1):28-35.

PMID:
12656935
4.

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.

Isojärvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV.

N Engl J Med. 1993 Nov 4;329(19):1383-8.

5.

Altered ovarian function and cardiovascular risk factors in valproate-treated women.

Isojärvi JI, Taubøll E, Pakarinen AJ, van Parys J, Rättyä J, Harbo HF, Dale PO, Fauser BC, Gjerstad L, Koivunen R, Knip M, Tapanainen JS.

Am J Med. 2001 Sep;111(4):290-6.

PMID:
11566460
6.

Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women?

Akdeniz F, Taneli F, Noyan A, Yüncü Z, Vahip S.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Feb;27(1):115-21.

PMID:
12551733
7.

Screening for bipolar disorder in women with polycystic ovary syndrome: a pilot study.

Klipstein KG, Goldberg JF.

J Affect Disord. 2006 Apr;91(2-3):205-9. Epub 2006 Feb 17. Erratum in: J Affect Disord. 2007 Jan;97(1-3):277.

PMID:
16487597
8.

Reproductive function and risk for PCOS in women treated for bipolar disorder.

Rasgon NL, Altshuler LL, Fairbanks L, Elman S, Bitran J, Labarca R, Saad M, Kupka R, Nolen WA, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Leverich G, Grunze H, Walden J, Post R, Mintz J.

Bipolar Disord. 2005 Jun;7(3):246-59.

PMID:
15898962
9.

Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder.

Joffe H, Cohen LS, Suppes T, McLaughlin WL, Lavori P, Adams JM, Hwang CH, Hall JE, Sachs GS.

Biol Psychiatry. 2006 Jun 1;59(11):1078-86. Epub 2006 Jan 31.

PMID:
16448626
10.

Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls.

Joffe H, Kim DR, Foris JM, Baldassano CF, Gyulai L, Hwang CH, McLaughlin WL, Sachs GS, Thase ME, Harlow BL, Cohen LS.

J Clin Psychiatry. 2006 Feb;67(2):297-304.

PMID:
16566627
11.

Valproate treatment and the risk of hyperandrogenism and polycystic ovaries.

Soares JC.

Bipolar Disord. 2000 Mar;2(1):37-41.

PMID:
11254018
12.

Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report.

Joffe H, Cohen LS, Suppes T, Hwang CH, Molay F, Adams JM, Sachs GS, Hall JE.

Biol Psychiatry. 2006 Dec 15;60(12):1378-81. Epub 2006 Sep 1.

PMID:
16950230
13.

Appropriate clinical management of women taking valproate.

Piontek CM, Wisner KL.

J Clin Psychiatry. 2000 Mar;61(3):161-3. No abstract available.

PMID:
10817097
14.

Polycystic ovary syndrome in women using valproate: a review.

Bilo L, Meo R.

Gynecol Endocrinol. 2008 Oct;24(10):562-70. doi: 10.1080/09513590802288259. Review.

PMID:
19012099
15.

A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders.

Joffe H, Hall JE, Cohen LS, Taylor AE, Baldessarini RJ.

Harv Rev Psychiatry. 2003 Mar-Apr;11(2):99-108. Review. No abstract available.

PMID:
12868510
16.

Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases.

Isojarvi JI, Tapanainen JS.

Arch Neurol. 2000 Jul;57(7):1064-8.

PMID:
10891991
17.

Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study.

Sahota P, Prabhakar S, Kharbanda PS, Bhansali A, Jain V, Das CP, Modi M.

Epilepsia. 2008 Dec;49(12):2069-77. doi: 10.1111/j.1528-1167.2008.01676.x. Epub 2008 May 21.

18.

Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study.

Prabhakar S, Sahota P, Kharbanda PS, Siali R, Jain V, Lal V, Khurana D.

Epilepsia. 2007 Jul;48(7):1371-7. Epub 2007 Apr 18.

19.

Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review.

Reynolds MF, Sisk EC, Rasgon NL.

Curr Med Chem. 2007;14(26):2799-812. Review.

PMID:
18045126
20.

Longitudinal evaluation of reproductive function in women treated for bipolar disorder.

Rasgon NL, Reynolds MF, Elman S, Saad M, Frye MA, Bauer M, Altshuler LL.

J Affect Disord. 2005 Dec;89(1-3):217-25. Epub 2005 Sep 19.

PMID:
16171873

Supplemental Content

Support Center